Cyclotron

Best Nomos, A TeamBest Global Company, Launches Its Most Modern, Highly Innovative Compact SONALIS Ultrasound System

Retrieved on: 
Lundi, avril 29, 2024
Medical Devices, Surgery, Neurology, Health Technology, Cardiology, Biotechnology, Radiology, General Health, Health, Oncology, Brachytherapy, System, Prostate, Mammography, LDR, Compact, Human musculoskeletal system, BCF, HD, Cyclotron, HDR, Health physics, TBG, Diagnosis, Perineum, Breast cancer, Medical imaging

Best Nomos, a TeamBest Global Company, is launching its most modern, highly innovative Compact SONALIS Ultrasound System .

Key Points: 
  • Best Nomos, a TeamBest Global Company, is launching its most modern, highly innovative Compact SONALIS Ultrasound System .
  • With its previous hallmark, patented SimulView™ Technology, the system provides superior visualization of HDR, LDR, Tranperineal Biopsies, fiducial marker placements, or any other procedure that can be performed with a transrectal ultrasound system.
  • SimulView™ Technology provides simultaneous “live” views of the prostate in both planes, thereby increasing treatment accuracy and precision.
  • To see a video about Best Nomos's Compact Sonalis Ultrasound System, please go to http://www.teambest.com/videos/Best-nomos-Compact-Sonalis-1080p.mp4 .

ASP Isotopes Issues Letter to Stockholders

Retrieved on: 
Jeudi, avril 11, 2024
Consensus, FDA, Nuclear energy, Uranium, Memorandum, Void coefficient, SMR, Intelligence, Prostate cancer, Isotope, ASP, Silicon, Annual report, Yoy, PET, Semiconductor, Private, DOE, Acceleration, Safety, GE HealthCare, Small modular reactor, Artificial intelligence, Coal, Nuclear Energy Institute, Exercise, Isotopes of ytterbium, NEI, Cyclotron, Laser, Radiopharmaceutical, Government, FDG, Silane, Sale, Lithium, Lutetium (177Lu) vipivotide tetraxetan, LEU, Lutetium, Radionuclide, Electronics, ASPI, Letter, Growth, Rare-earth element

WASHINGTON, April 11, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASPI,” or the “Company”), an advanced materials company dedicated to the development of technology and processes designed to produce isotopes used in multiple industries, today released the following letter to stockholders from its Chairman and CEO, Paul Mann.

Key Points: 
  • WASHINGTON, April 11, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASPI,” or the “Company”), an advanced materials company dedicated to the development of technology and processes designed to produce isotopes used in multiple industries, today released the following letter to stockholders from its Chairman and CEO, Paul Mann.
  • The contract required RC14 to provide an irrevocable standby letter of credit in lieu of a deposit, which was received.
  • Our proprietary technology has proven capabilities to enrich a wide range of isotopes, including light isotopes and lighter molecules, such as silane (SiH4).
  • ASP Isotopes’ goal is to become the lowest cost and most reliable supplier of stable isotopes globally.

Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.

Retrieved on: 
Jeudi, avril 11, 2024
Health, Transport, Logistics, Supply Chain Management, Health Technology, Pharmaceutical, Biotechnology, USD, Isotope, BC Cancer Agency, Actinium-225, PET, History, Cyclotron, Patient, GHS, Acquisition, Lawson Health Research Institute, TRIUMF

ARTMS Inc. (ARTMS) is pleased to announce that the acquisition by Telix Pharmaceuticals Limited (Telix) has been completed.

Key Points: 
  • ARTMS Inc. (ARTMS) is pleased to announce that the acquisition by Telix Pharmaceuticals Limited (Telix) has been completed.
  • This acquisition further enhances the vertical integration of Telix’s supply chain and manufacturing by providing a greater level of supply chain and regulatory control over the production of key isotopes.
  • The history of ARTMS is rooted in a Canadian government funded project focused on solid target production of 99mTc.
  • Solomon Partners Securities LLC acted as financial advisor and Norton Rose Fulbright Canada LLP acted as legal advisor to ARTMS during the negotiations and due diligence process related to the acquisition by Telix.

RLS Radiopharmacies Partners with Eckert & Ziegler to Expand Production of Gallium-68-Based Radiopharmaceuticals

Retrieved on: 
Jeudi, avril 4, 2024
Oncology, Medical Devices, Health, Radiology, Pharmaceutical, Biotechnology, Gallium, Diagnosis, Radionuclide, Glomus tumor, Prostate cancer, USP, Half-life, Actinium-225, Partnership, Patient, Pharmacy, RLS, PET, Splenic infarction, Cancer, SDAX, Radiopharmaceutical, Investment, Cyclotron, ISO, Positron emission tomography, DSM-IV codes, Gelastic seizure, Medical imaging

Under the partnership, all 31 of RLS’s radiopharmacies will be equipped with Eckert & Ziegler’s advanced GalliaPharm® generators, which the radiopharmacy network will utilize to produce high-quality, life-enhancing Gallium-68-based (Ga-68) radiopharmaceuticals.

Key Points: 
  • Under the partnership, all 31 of RLS’s radiopharmacies will be equipped with Eckert & Ziegler’s advanced GalliaPharm® generators, which the radiopharmacy network will utilize to produce high-quality, life-enhancing Gallium-68-based (Ga-68) radiopharmaceuticals.
  • “A powerful diagnostic isotope, Gallium has an extremely short half-life, necessitating the need for Ga-68-based radiopharmaceuticals to be produced within minutes of patient dosing.
  • This signifies a major leap forward in our commitment to advancing healthcare and improving patient outcomes through cutting-edge radiopharmaceuticals."
  • To date, RLS has installed Eckert & Ziegler’s GalliaPharm® generators within most of its locations and anticipates the remaining radiopharmacies will be operational by the end of June.

Actinium Pharmaceuticals Launches Actinium-225 Focused Strategic Initiative to Leverage Proprietary Cyclotron Based Manufacturing Technology to Address Growing Market Demand

Retrieved on: 
Lundi, mars 11, 2024
Actinium, Synthase, NCI, Recycling, Actinium-225, International, CRADA, DNA, Research, Thorium, Linear energy transfer, Investment, Cyclotron, DOE, Medicine

Actinium's intellectual property portfolio relating to its cyclotron-based production method includes 5 issued U.S. patents and 49 issued international patents as well as significant technical know-how.

Key Points: 
  • Actinium's intellectual property portfolio relating to its cyclotron-based production method includes 5 issued U.S. patents and 49 issued international patents as well as significant technical know-how.
  • The DOE has stated that it is exploring the generation of new thorium cows and production via a cyclotron.
  • Based on our experience to date, we expect to be able to produce material with high radiochemical purity and at yields not possible with thorium-cow based methods.
  • This has the potential to further establish Actinium as a leader in alpha-particle therapies and remain at the forefront of innovation while addressing a significant and rapidly growing addressable patient population."

Expanding the Reach of Care for Cancer and Other Disease States: BAMF Health and GE HealthCare collaborate to enable sustainable and scalable solutions for growth in Theranostics

Retrieved on: 
Lundi, novembre 13, 2023
Other Health, Software, General Health, Pharmaceutical, Oncology, Technology, Infectious Diseases, Hospitals, Artificial Intelligence, Health Technology, Other Technology, Health, BAMF, PET/CT, SPECT/CT, PET/MR, Patient, Multimedia, Alzheimer's disease, Molecular imaging, Cyclotron, Cancer, Drug development, GE HealthCare, Medical imaging, Personalized medicine

As demand for Theranostic care increases, GE HealthCare and BAMF Health are excited to announce a collaboration aimed at enabling BAMF Health to scale turnkey offerings inclusive of leading GE HealthCare technologies and services.

Key Points: 
  • As demand for Theranostic care increases, GE HealthCare and BAMF Health are excited to announce a collaboration aimed at enabling BAMF Health to scale turnkey offerings inclusive of leading GE HealthCare technologies and services.
  • The goal of the collaboration is to ensure an agile go-to-market approach to enhance the adoption of Theranostics solutions in the U.S.
  • The arrangement supports a shared interest in better patient outcomes made possible through advanced diagnostics and radiotherapeutics.
  • The collaboration between GE HealthCare and BAMF Health will leverage both partners’ deep understanding of the complexities of delivering Theranostic care to establish a framework to support the scalable infrastructure and clinical solutions for expanded adoption of precision care.

Cyclotron is a proud participant in the Microsoft Security Copilot Partner Private Preview

Retrieved on: 
Mercredi, novembre 15, 2023
Corporation, SAN, Organization, Microsoft Security Essentials, Risk, Ecosystem, Intelligence, API, Partnership, AI, Microsoft, LLM, Video game, Cyclotron

SAN FRANCISCO, Nov. 15, 2023 /PRNewswire-PRWeb/ -- Cyclotron is thrilled to announce its participation in the Microsoft Security Copilot Partner Private Preview, a testament to its dedication to security and innovation. Cyclotron has been selected based on its impressive track record with Microsoft Security technologies, its eagerness to explore and provide invaluable feedback on cutting-edge functionality, and its strong partnership with Microsoft.

Key Points: 
  • Cyclotron, a leader in innovation, joins Microsoft's Security Copilot Partner Private Preview, showcasing its commitment to security.
  • Selected for its expertise and partnership, Cyclotron actively collaborates with Microsoft to shape the groundbreaking AI-powered Security Copilot, revolutionizing the industry and enhancing organizations' defense capabilities
    SAN FRANCISCO, Nov. 15, 2023 /PRNewswire-PRWeb/ -- Cyclotron is thrilled to announce its participation in the Microsoft Security Copilot Partner Private Preview, a testament to its dedication to security and innovation.
  • "Our collaboration with Microsoft in the Security Copilot Partner Private Preview is a testament to Cyclotron's unwavering commitment to security and innovation, stated Cyclotron CEO Amber Bahl.
  • Cyclotron is actively collaborating with Microsoft product teams to influence the development of the Security Copilot product in several ways.

King Faisal Specialist Hospital and Research Centre Seeks to Achieve Self-Sufficiency in Radiopharmaceuticals in the Kingdom

Retrieved on: 
Lundi, octobre 30, 2023
RC, Education, Radiopharmaceutical, Good manufacturing practice, Cyclotron, ISO 9001, Research, KFSH, King Faisal Specialist Hospital and Research Centre, Hospital, Saudi Food and Drug Authority, GMP, Nuclear medicine, PET/CT, Patient, ISO, SFDA, Medical imaging, Kingdom

Since its establishment, the department has produced over 25 types of radiopharmaceuticals with a production capacity exceeding 600,000 radiopharmaceutical preparations.

Key Points: 
  • Since its establishment, the department has produced over 25 types of radiopharmaceuticals with a production capacity exceeding 600,000 radiopharmaceutical preparations.
  • The department continues to provide its products to over 50 specialized Saudi medical centers, aiming to achieve self-sufficiency in the field of radiopharmaceuticals in the Kingdom of Saudi Arabia.
  • The Cyclotron and Radiopharmaceuticals Department aspires to become a diagnostic and molecular imaging center and the first facility for Technetium-99m (Tc-99m) generators in the Kingdom.
  • It conducts research to develop high-quality radiopharmaceuticals for KFSH&RC and other hospitals throughout the Kingdom to meet all healthcare needs of patients.

ASP Isotopes Inc. Enters Strategic Relationship With PET Labs Pharmaceuticals for the Distribution of Medical Isotopes

Retrieved on: 
Dimanche, octobre 29, 2023
Science, Radionuclide, Radiopharmaceutical, GE HealthCare, Piper, DLA Piper, PET, Cyclotron, Growth, Isotope, DLA, SPECT, Nuclear medicine, African, Patient, ASPI, Medical imaging

PET Labs is a South African radiopharmaceutical operations company dedicated to nuclear medicine and the science of radiopharmaceutical production.

Key Points: 
  • PET Labs is a South African radiopharmaceutical operations company dedicated to nuclear medicine and the science of radiopharmaceutical production.
  • PET Labs focuses on the production of fluorinated radioisotopes and active pharmaceutical ingredients.
  • PET Labs currently operates a single cyclotron in Pretoria, South Africa.
  • The primary objective of the relationship is to expand into frontier markets where there is an undersupply of radioisotopes used in medical imaging.

Letter to ViewRay Lenders/Investment Bankers and Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies

Retrieved on: 
Mardi, octobre 17, 2023
Technology, Medical Devices, Hospitals, FDA, Health Technology, Software, Biotechnology, Radiology, Health, Oncology, TBG, BMI, Cyclotron, Family, Synchrotron, Seed, Gold, Radiation, Radiation therapy, Research

TeamBest Global (TBG) is a lean enterprise consisting of multiple companies, some of which were failing when Krishnan Suthanthiran acquired them.

Key Points: 
  • TeamBest Global (TBG) is a lean enterprise consisting of multiple companies, some of which were failing when Krishnan Suthanthiran acquired them.
  • TBG companies have grown to support 450+ employees globally and work to revitalize struggling companies with new product lines.
  • Suthanthiran considers his staff his family, striving daily to ensure that employees—along with suppliers and contractors—are paid and customers are happy and satisfied.
  • His companies offer a wide range of cyclotrons and synchrotrons for radioisotope production, research, and therapy.